The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Havers had led the CDC's Respiratory Virus Hospitalization Surveillance Network, or RESP-NET, that collects and studies trends in hospitalizations from COVID-19, RSV and influenza.

Havers had led the CDC's Respiratory Virus Hospitalization Surveillance Network, or RESP-NET, that collects and studies trends in hospitalizations from COVID-19, RSV and influenza.

Among patients with systemic autoimmune rheumatic diseases, hospitalization due to COVID-19 was more than twice as likely in those using glucocorticoids or CD20 inhibitors, according to data ...

Researchers further found that total hospitalization costs amounted to significantly more among those with COVID-19 pneumonia vs. non-COVID-19 pneumonia (mean, $1,278,270 vs. $967,866; P = .002).

COVID-19 outcomes including all-cause hospitalization, all-cause mortality, and hospitalization for various organ-specific disorders linked to psychiatric, respiratory, neurological ...

The original phase II/III EPIC-HR trial showed that nirmatrelvir/ritonavir (Paxlovid) was nearly 89% effective for preventing COVID hospitalization and all-cause death in unvaccinated high-risk ...